Web Analytics

3 Latest Announced Rounds

  • $109,315,123
    Series C

    1 Investors

    Aviation and Aerospace Component Manufacturing
    Apr 23rd, 2024
  • $3,455,284
    Unknown

    4 Investors

    Entertainment Providers
    Apr 23rd, 2024
  • $11,000,000
    Unknown

    1 Investors

    Real Estate
    Apr 23rd, 2024
$1,188.49M Raised in 68 Funding Rounds in the past 7 Days - View All

Funding Round Profile

InStride Health

start up
United States - Boston
  • 02/04/2024
  • Series B
  • $30,000,000

InStride Health is a specialty pediatric anxiety/OCD outpatient treatment program that uses evidence-based care (CBT, ACT, DBT) with an emphasis on exposure therapy. Our highly-experienced care team including a psychiatrist, therapist and exposure coach, teaches patients and families the skills and strategies needed to quickly get their lives back on track. InStride provides insurance-based access to a human-first, fully virtual personalized treatment plan that fits into your life and has proven as effective as in-person treatment for anxiety/OCD. More than a continuum of care—InStride is a pathway to a healthier life and hope for a more promising future.


Related People

John VoithFounder

John Voith United States - Greater Boston

With over 14 years of experience in health care entrepreneurship, I am passionate about creating mission-oriented companies that deliver high-quality, accessible, and patient-centered care. Currently, I am the CEO and Co-Founder of InStride Health, an outpatient treatment provider for kids, teens, and young adults experiencing moderate to severe anxiety and/or OCD. In collaboration with McLean Hospital, we offer comprehensive, evidence-based therapies that are covered by insurance and tailored to each patient's needs and goals.

Before InStride, I led Virtudent, a teledentistry company that brought preventive dental care to workplaces and the community. I scaled the company from a start-up to a national leader in oral health innovation, serving thousands of patients and partners across the US. I also have a strong background in interoperability, strategy, and business development, having held various leadership roles at athenahealth and IMS Health. I hold an MBA from The Wharton School, an MPA from Harvard Kennedy School, and a BA in Biology and Public Policy from Harvard University.